Plain-English translation of NCT04039945 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →Fr1da is a large screening study that tests children ages 2–10 and relatives of people with type 1 diabetes (ages 1–21) for early signs of the disease. The goal is to identify type 1 diabetes in its earliest stages, before serious complications occur, so that early support and preventive treatments can begin right away.
Type 1 diabetes can develop suddenly and lead to a life-threatening emergency called ketoacidosis. By catching the disease early through screening, doctors hope to prevent this crisis, reduce stress and anxiety for families, and possibly slow or prevent the disease from progressing in the first place.
You likely qualify if…
You likely don't qualify if…
You will have a simple blood test performed at your pediatrician's office, usually during a routine checkup or at a scheduled screening visit. The screening is designed to be quick and done as part of normal healthcare. Depending on your age group, you may be invited back for a second screening after some time. If early signs of type 1 diabetes are found, you will be invited to receive support and counseling from a specialized team.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
Germany
Enrollment target
~285,000 participants
Started
February 2015
Primary completion
December 2028
Age range
2 Years – 10 Years
Last updated on clinicaltrials.gov in December 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Anette-Gabriele Ziegler, Prof.Dr.med.
Helmholtz Zentrum München
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.